All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
XBI real return snapshot: After CPI-U inflation, XBI returned +56.09% over the past year and +1.70% YTD, with dividends reinvested. Since Feb. 6, 2006, XBI is up +388.85% in real purchasing-power return, or +8.14%/yr, and is currently ā42.05% below its real total-return high on Feb. 8, 2021.
| Mon 2006-02-06? to Mon 2026-05-18 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| XBI × |
+1.70%
2026-05-18 |
+56.09%
2026-05-18 |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Mon 2006-02-06? to Mon 2026-05-18 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| XBI × |
+388.85%
+8.14%/yr |
+9.85%/yr
(R2=0.755) |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Mon 2006-02-06? to Mon 2026-05-18 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| XBI × |
$10,000.00
2006-02-06 |
$48,884.55
2026-05-18 |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Year | XBI |
|---|---|
| 2026 (YTD) | +1.70% |
| 2025 | +32.35% |
| 2024 | ā1.82% |
| 2023 | +4.11% |
| 2022 | ā30.37% |
| 2021 | ā25.68% |
| 2020 | +46.34% |
| 2019 | +29.60% |
| 2018 | ā16.86% |
| 2017 | +40.80% |
| 2016 | ā17.16% |
| 2015 | +12.75% |
| 2014 | +43.89% |
| 2013 | +46.19% |
| 2012 | +30.43% |
| 2011 | +2.23% |
| 2010 | +15.87% |
| 2009 | ā2.30% |
| 2008 | ā8.65% |
| 2007 | +23.96% |
| 2006 | ā7.89% |
| Mon 2006-02-06? to Mon 2026-05-18 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| XBI × |
ā42.05%
from 2021-02-08 peak |
ā68.61%
2023-10-27 from 2021-02-08 peak |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Period ending Mon 2026-05-18 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| XBI × | +56.09% |
+32.39% +15.05%/yr |
+37.94% +11.32%/yr |
ā18.84% ā4.09%/yr |
+74.84% +5.75%/yr |
|
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||